STAGE II NON-SMALL CELL LUNG CANCER
Clinical trials for STAGE II NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE II NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for STAGE II NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Vaccine-Immunotherapy combo tested in Tough-to-Treat lung cancer
Disease control CompletedThis study tested whether combining a cancer vaccine (TG4010) with an immunotherapy drug (nivolumab) could help control advanced non-small cell lung cancer in patients whose previous treatments had stopped working. The vaccine aims to train the immune system to recognize and atta…
Matched conditions: STAGE II NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Megan Daly, MD • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Early trial tests adding immunotherapy to standard lung cancer care
Disease control CompletedThis early-stage study tested the safety of adding a newer immunotherapy drug (pembrolizumab) to the standard treatment of chemotherapy and radiation for patients with inoperable, locally advanced non-small cell lung cancer. The main goal was to find the safest dose and understan…
Matched conditions: STAGE II NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC